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Abstract
Background: Somatic comorbidities are a serious problem in patients with severe mental illnesses. These
comorbidities often remain undiagnosed for a long time. In Germany, physicians are not allowed to access patients’
health insurance data and do not have routine access to documentation from other providers of health care.
Against this background, the objective of this article was to investigate psychiatrists’ knowledge of relevant somatic
comorbidities in their patients with severe mental illnesses.
Methods: Cross-sectional secondary data analysis was performed using primary data from a prospective study
evaluating a model of integrated care of patients with serious mental illnesses. The primary data were linked with
claims data from health insurers. Patients’ diagnoses were derived on the basis of the ICD-10 and the Anatomical
Therapeutic Chemical (ATC) classification system. Diabetes, hypertension, coronary artery disease (CAD),
hyperlipidaemia, glaucoma, osteoporosis, polyarthritis and chronic obstructive pulmonary disease (COPD) were
selected for evaluation. We compared the number of diagnoses reported in the psychiatrists’ clinical report forms
with those in the health insurance data.
Results: The study evaluated records from 1,195 patients with severe mental illnesses. The frequency of
documentation of hypertension ranged from 21% in claims data to 4% in psychiatrists’ documentation, for COPD
from 12 to 0%, respectively, and for diabetes from 7 to 2%, respectively. The percentage of diagnoses deduced
from claims data but not documented by psychiatrists ranged from 68% for diabetes and 83% for hypertension, to
90% for CAD to 98% for COPD.
Conclusions: The majority of psychiatrists participating in the integrated care programme were insufficiently aware
of the somatic comorbidities of their patients. We support allowing physicians to access patients’ entire medical
records to increase their knowledge of patients’ medical histories and, consequently, to increase the safety and
quality of care.
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Background
People with severe mental illnesses often have somatic
comorbidities, meaning that one or more somatic dis-
eases co-occur with the mental illness. In many cases,
this phenomenon can be ascribed to a mutual depend-
ence between the psychiatric illness and the somatic dis-
ease [1]. In fact, higher risks of getting a psychiatric
disorder were shown for persons with somatic diseases
[2]. On the other hand, also the risk of having a somatic
disease is approximately twice as high for persons with
severe mental illnesses than for people without mental
disorders [3]. Thirty to fifty percent of patients experien-
cing psychiatric disorders have clinically relevant comor-
bid physical diseases [4], including cardiovascular
disease, diabetes mellitus and respiratory and lung dis-
eases [4–8]. In patients with severe mental illnesses,
physical comorbidities often remain undiagnosed for a
longer period of time than in those without severe men-
tal illnesses [4, 9]. Many people with severe mental
illnesses do not have or rarely consult a general practi-
tioner and are confronted with various other barriers to
receiving care [10–12].
Physicians working in the German health care system
are not allowed to access patients’ health insurance data
and do not have routine access to documentation from
other providers of health care, in contrast to, e.g., UK and
Denmark. To obtain information on comorbid diseases
and other health care usage data, physicians must inter-
view the patient or his/her relatives and actively order
medical notes from colleagues in other specialties. Physi-
cians need to rely on the completeness of the information
given by the patient. This increases the risk that psychia-
trists are not aware of comorbidities in patients with se-
vere mental illnesses, which is problematic, e.g., when
prescribed psychotropic drugs interact with drugs pre-
scribed for somatic diseases by other physicians [13–16].
In this paper, we focus on psychiatrists’ awareness of their
patients’ somatic comorbidities. We use data from a Ger-
man pre-post study that evaluated the costs of a model of
integrated health care for patients with serious mental ill-
nesses [17]. The integrated health care programme com-
prises complex outpatient treatment provided by, e.g.,
psychiatrists and psychiatric nurses, general practitioners,
clinicians and social workers. Inclusion in the programme
substituted for an otherwise necessary hospitalisation. The
study reported insufficient documentation of common
somatic diseases by the treating psychiatrists. The purpose
of this article was to compare the presence of selected som-
atic diseases in patients with severe mental illnesses with
the frequency of documentation of these diseases by the
treating psychiatrists. The selected somatic diseases were
diabetes, hypertension, coronary artery disease (CAD),
hyperlipidaemia, glaucoma, osteoporosis, polyarthritis and
chronic obstructive pulmonary disease (COPD).
Methods
Study design
We performed a cross-sectional secondary data analysis
based on a prospective, multi-centre, non-controlled obser-
vational study of an integrated care model in mental health
[17]. The study was approved by the institutional ethics
committee of the Charité–Universitätsmedizin Berlin.
Study population and data sources
All patients who were insured by DAK-Gesundheit
health insurance or a health insurance company belong-
ing to the group BKK VAG Mid-Germany and who were
newly included in the integrated health care programme
between July 2007 and December 2009 in Berlin/Bran-
denburg and Lower Saxony were eligible to participate
in this study. Detailed inclusion and exclusion criteria
are reported elsewhere [17]. Briefly, patients were in-
cluded in the integrated health care programme if they
had an ICD-10 diagnosis within the range of F0.X to
F8.X, showed seriously impaired social functioning as
defined by a Global Assessment of Functioning (GAF)
score of less than or equal to fifty, exhibited a severity
score greater than or equal to five on the Clinical Global
Impression (CGI) Scale and were at least 18 years old.
Persons rated by the treating psychiatrist as having acute
suicidal tendencies or a high likelihood of discontinuing
treatment were excluded; the former were directly
referred to inpatient treatment [17].
From a sample of 1,364 patients in the integrated care
model, we created a subsample for the present analysis
by excluding patients with BKK statutory health insur-
ance (n = 145) due to lack of permission to use their data
as well as patients without existing clinical report forms
from their treating psychiatrist and health insurance
company data (n = 24) (see Fig. 1). The analysed sub-
sample contained 1,195 participants. Psychiatrists’ clin-
ical report forms were available from July 2007 to
December 2009. In contrast, health insurance data were
available from 31 July 2003 (first entry) to 31 December
2009 (last entry).
Psychiatrists documented relevant study information
on medical history and the clinical status of their pa-
tients in clinical report forms containing socio-
demographic data, medical history, ICD-10 codes for
current psychological and somatic diagnoses, GAF
scores, CGI scores and specific psychopathological
scales. The GAF is a numeric scale that evaluates the
psychological, social and occupational functioning of
adults [18]. The CGI scale describes the severity of an
illness [19]. The main psychiatric diagnosis, which was
documented by the psychiatrists, was defined as being
the one that resulted in the patient’s inclusion in the
outpatient integrated care programme. Completeness of
documentation was achieved as much as possible by a
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standardised query system used by the study personnel.
If psychiatrists did not list any somatic comorbidities on
a patient’s clinical report form, we assumed that no som-
atic comorbidities were known to them.
Deriving ICD-diagnoses from ATC-Codes
The health insurance data contributed for each study par-
ticipant comprised all Anatomical Therapeutic Chemical
(ATC) classification codes for medications prescribed to
the patient and ICD-10 codes if the patient was hospita-
lised, stayed at a rehabilitation centre or received an illness
certificate. Somatic diagnoses were deduced either directly
from the ICD-10 codes or indirectly from the medication
regimen, as proposed by previous studies [20–24]. For our
analysis, we selected highly prevalent somatic diseases
with clinical relevance to patients with severe mental ill-
nesses [1, 4, 25–27] or with an increased risk of severe
interactions with common medications used for the treat-
ment of severe mental illnesses [4, 13–16]. The selected
somatic diseases were diabetes, hypertension, coronary
artery disease (CAD), hyperlipidaemia, glaucoma, osteo-
porosis, polyarthritis and chronic obstructive pulmonary
disease (COPD). Their respective ICD-10 codes and ATC
codes for specifically prescribed drugs are listed in Table 1.
Somatic diseases that could not unequivocally be deduced
from the ATC codes of the prescriptions, such as stroke,
epilepsy or Parkinson’s disease, were not considered, al-
though they may be highly prevalent.
Assessment of psychiatrists’ knowledge
For each selected disease, we counted the number of pa-
tients for whom psychiatrists documented the respective
diagnosis, as well as those for whom a diagnosis was de-
rived on the basis of the health insurance data. Percent-
ages were calculated by dividing the respective numbers
by N = 1,195. To assess psychiatrists’ knowledge of their
patients’ somatic diseases, the frequency of documenta-
tion of somatic diseases was descriptively compared
using both psychiatrists’ clinical report forms and health
insurance data for the following three steps of analysis:
First, we determined the number of somatic diagnoses
documented by psychiatrists that were also derived from
the health insurance data. Second, we determined the
number of diagnoses that were documented by psychia-
trists but not documented in the health insurance data.
Third, we determined the number of diagnoses reported
solely in the health insurance data.
Sensitivity analysis
We performed a sensitivity analysis to verify the validity
of our defined ATC code criteria for the detection of dis-
eases. For each of the selected diseases, we investigated
how many patients with an ICD-10 diagnosis were also
identified by the defined ATC codes.
A descriptive statistical analysis was performed using
R version 3.0.0 [28].
Results
Baseline characteristics
Table 2 shows the baseline characteristics of the study
population. A total of 1,195 patients experiencing a
psychiatric disorder, 69% of whom were females, were
included in the study. The mean patient age at entry into
the integrated care model was 48.0 ± 16.1 years. More
than half of the patients had an affective disorder as their
main psychiatric diagnosis. Schizophrenia, schizotypal and
delusional disorders were documented as the main
diagnoses in approximately one fifth of the patients.
Psychiatrists’ awareness of their patients’ comorbidities
The health insurance data contained 4,891 ICD-10 code
entries and 96,951 ATC code entries for the 1,195 pa-
tients, of which 112 (2%) and 4,973 (5%), respectively,
were missing, i.e., an insurance number and/or a date
was listed without an ICD-10 or ATC code.
The number of patients for whom a diagnosis was
documented by the psychiatrist and the number of
Fig. 1 Study design and data management
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patients who were diagnosed on the basis of the health
insurance data differed widely (see Table 3). The fre-
quency of documentation in the psychiatrists’ clinical
report forms was very low, with hypertension (4%) and
diabetes (2%) being the most commonly documented dis-
eases. The frequency of documentation of the remaining
diseases ranged from 0 to 1%. When combining data from
health insurers and the psychiatrists’ clinical report forms,
hypertension was the most frequently diagnosed disease
(23%), followed by hyperlipidaemia (13%), COPD (12%)
and diabetes (7%). Distinctly lower frequencies were ob-
served for glaucoma (3%), CAD (3%), osteoporosis (2%),
and polyarthritis (1%). Of all the patients in this study, 728
(61%) had no somatic comorbidities, and 272 (23%), 123
(10%) and 72 (6%) had one, two or three or more somatic
comorbidities, respectively.
When comparing diagnoses documented by psychia-
trists and diagnoses derived from health insurance data,
fewer than 30% of diagnoses were reported in both data
sources (see Table 3). This percentage was less than 10%
for hypertension, CAD, hyperlipidaemia, glaucoma, poly-
arthritis and COPD. Patients for whom a diagnosis was
documented by a psychiatrist but not documented in
health insurance data were infrequent (less than 10% of
the diagnosed patients). The majority of diagnoses (68 to
98%) were identified in the health insurance data but not
documented by psychiatrists.
Sensitivity analysis
We investigated how many patients with an ICD-10
code in their health insurance data were also diagnosed
by ATC codes. For the majority of diseases, 52 to 75%
were diagnosed by both codes (see Table 4). However,
none of the four cases of polyarthritis diagnosed by
ICD-10 code could be identified by the ATC criteria.
Discussion
Our analysis showed that psychiatrists’ documentation of
somatic comorbidities in their patients was very low. The
percentage of diagnoses that were documented in health
insurance data but not by psychiatrists ranged from 68%
for diabetes to 98% for COPD. This constitutes a problem,
as many patients within our selected study population also
Table 1 Predefined criteria for selected somatic diseases using ICD-10 and ATC codes for prescribed medicationsa
Disease ICD-10 code in health
insurance data
ATC code prescription documented in health insurance data
Diabetes E10-E14, G6320 A10 (at least one time)
Hypertension I10-I15 C02 (at least twice within 90 days) OR
at least two different ATC codes [C02, C03, C07, C08 or C09] (within 90 days)
CAD I20-I25 No distinct diagnosis by means of ATC codes
Hyperlipidaemia E780-E785 C10 (at least one time)
Glaucoma H40, H42 S01E (at least twice within 90 days) AND manual review by a physician to identify
patterns and decide individually
Osteoporosis M80-M82 At least two ATC codes [G03XC01, H05, M05BA or M05BB] (within 90 days)
Polyarthritis M05-M09 At least three ATC codes [M01B, M01CA, M01CB, M01CX, M02, L04AA13, L04AB01,
L04AB04 or L04AX03] (within 180 days) AND manual review by a physician to identify
patterns and decide individually
COPD J44, J4200, J4390 At least three ATC codes [R03, R05] (within 180 days)
aproposed by previous studies [20–24]
Table 2 Baseline characteristics of the study population
N = 1,195 Number Percent





F0 Organic, including symptomatic,
mental disorders
57 5%
F1 Mental and behavioural disorders
due to psychoactive substance use
16 1%
F2 Schizophrenia, schizotypal and
delusional disorders
234 20%
F3 Mood [affective] disorders 681 57%
F4 Neurotic, stress-related and
somatoform disorders
137 12%
F6 Disorders of adult personality and behaviour 28 2%
F8 Disorders of psychological development 1 0%
Information missing 41 3%
Clinical Global Impression (CGIb) (mean ± SD)a 5.3 ± .7
Global Assessment of Functioning (GAFc)
(mean ± SD)a
36.7 ± 8.8
aThese numbers are from the first quarter of inclusion in the integrated health
care programme
bPossible scores for CGI range from 1 to 7, with higher scores indicating more
severe illness
cPossible scores for GAF range from 0 to 100, with higher scores indicating
better psychological, social and occupational functioning


































































































































































































































































































































































































































































Dornquast et al. BMC Health Services Research  (2017) 17:162 Page 5 of 8
suffer from somatic diseases. The number of patients with
documentation of the selected somatic diseases ranged
from 1% for polyarthritis to 23% for hypertension.
One of the main limitations of this study was the fact
that relevant diagnoses could be missed in the health in-
surance data, as shown by our sensitivity analysis (see
Table 4). However, we only had access to ICD-10 codes
reported to a health insurer from hospitalisations, stays
at rehabilitation centres and illness certificates. Data
from the Association of Statutory Health Insurance -
accredited Physicians (Kassenärztliche Vereinigung),
which also contain ICD-10 codes originating from the
outpatient sector, as well as data from general practi-
tioners, were not available. Instead, we derived somatic
diagnoses from the ATC codes of prescribed drugs. This
method is more prone to omission and misclassification
of disease. Various diseases are difficult or impossible to
identify on the basis of ATC codes, e.g., CAD, heart
failure and pain syndromes.
We may have underestimated the frequency of somatic
diseases in this sample because a proportion of the pa-
tients studied may not have been treated for their som-
atic diseases and therefore would not have ATC codes in
their health insurance data, and some patients were
missing data from their health insurer. We expect that
either technical problems or changes in health insurers
are responsible for missing data, and hence we assume
that selection bias is not a problem. Another limitation
of our study is that, for certain patients, specific ATC
codes were documented at the end of the period for
which data were available. These patients were likely not
assigned a diagnosis because our definition of diagnoses
required several documentations of ATC codes within a
certain time period. Additionally, the different time
frames of the health insurance data and psychiatrists’
documentation obtained must be mentioned. However,
these different time frames do not represent a serious
constraint, as the selected somatic diseases are all
chronic or lifelong diseases.
Our work is also limited by the fact that we could not
discern why so many diagnoses were not documented by
psychiatrists. It is possible that a psychiatrist was aware of
a disease but did not document it in the clinical report
form. However, this is unlikely due to the elicitation of this
information in the context of a study, and a careful query
process used to request non-completed answers.
Our data stem from a specialised treatment setting.
However, the quality of documentation for the included
patients is expected to be even better, due to the re-
search setting in which it was gathered, than it would be
in a typical treatment setting. The quality of the routine
data from the health insurance company that were
added to the primary data did not differ between pa-
tients inside or outside integrated care models, as the
documented data are largely stipulated by the Germany
Social Insurance Code.
In conclusion, we do not see this as a limitation to the
validity of our results.
Previous studies have shown that many somatic dis-
eases in patients with severe mental illnesses remain un-
detected or undiagnosed by their psychiatrists. A study
conducted in 1989 reported that psychiatrists docu-
mented comorbidities in their patients in only 53% of
cases [9]. In our analysis, diabetes was the only disease
to be consistently documented by psychiatrists. This
may be because it is particularly important for psychia-
trists to know that their patients have been diagnosed
with diabetes, as atypical antipsychotics have a diabeto-
genic effect. Additionally, patients usually have a diabetic
ID card that can be shown to the psychiatrist. Such ID
cards comprise amongst others information about the
patients’ prescription schedule, dates of routine medicals
checks and current blood levels of laboratory indicators.
Furthermore, diabetes is a highly prevalent disease, and
psychiatrists may be more aware of this disease and may
ask about it more frequently.
Patients with severe mental illnesses are reported to be
less likely to self-report their medical conditions to a
Table 4 Sensitivity analysis
N = 1,195 Diagnosed by ICD-10 code (in health insurance data) Patients with somatic diagnoses derived from ATC criteria who also
had documented ICD-10 codes in the health insurance data (in %)
N N %
Diabetes 12 8 67%
Hypertension 48 25 52%
CAD 0 n.a.a
Hyperlipidaemia 0 0 0%
Glaucoma 5 3 60%
Osteoporosis 4 3 75%
Polyarthritis 4 0 0%
COPD 19 10 53%
aCAD patients were solely diagnosed by ICD-10 codes
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physician. They are also less likely to report that their
treating physician informed them about a co-occurring
somatic disease [29].
Finally, the frequency of documented somatic diseases
in our study population differed from those documented
by other studies. The CATIE-study from 2005 reported a
prevalence of hypertension of 27% for patients with
schizophrenia [30], and hypertension was the most
frequently diagnosed cardiovascular comorbidity in these
patients. We found similar results in our sample with
hypertension as most frequent documented disease (23%).
Additionally, the authors of the CATIE-study reported a
prevalence of diabetes of 13% in patients with schizophre-
nia, which is almost twice as high as the frequency of
documentation we calculated [30]. The frequency of som-
atic diseases we calculated is expected to be lower because
patients with other serious mental illnesses were included
in addition to patients experiencing schizophrenia. Those
patients are often treated with atypical antipsychotics,
which are known to have diabetogenic effects. Other stud-
ies reported similar prevalences as the CATIE-study [25,
31]. A study from 2004 reported a prevalence of COPD of
23% in patients with severe mental illnesses [32]. This pro-
portion is almost twice as high as the frequency we calcu-
lated in our sample (12%). This discrepancy is most likely
explained by the fact that we derived diagnoses from the
ATC codes of prescribed drugs. We were therefore more
likely to miss relevant diagnoses.
Conclusions
Many patients experiencing mental illnesses also have som-
atic diseases. These comorbidities pose challenges to the
management of the mental, medical and personal health of
a patient. Our data show that psychiatrists participating in
the integrated care programme were insufficiently aware of
the somatic comorbidities of their patients with psychiatric
disorders. It can be assumed that outside of a research
setting the level of awareness may be even lower.
Improved communication among physicians with dis-
tinct specialties is desirable to provide optimal therapy
for a patient. However, the implementation of improved
communication should not be the responsibility of the
physician alone. Physicians have heavy workloads and
may not be able to initiate an exchange of information
with colleagues who are treating the same patient. Im-
proved communication should be initiated and pro-
moted by administrative institutions through the use of
financial incentives or facilitated access to patients’ treat-
ment data (e.g., through the use of an electronic health
card). We support the idea of allowing physicians to
access patients’ entire medical records to increase their
knowledge of patients’ medical history and, conse-
quently, to increase the safety and quality of care.
Psychiatrists should also be aware that the treatment
of somatic diseases can affect psychiatric diseases and a
patient’s response to psychiatric treatment. Hence, psy-
chiatrists should obtain a thorough somatic medical his-
tory in their patient interviews. Because patients
experiencing psychiatric disorders often have significant
somatic comorbidities, and because of the associated
health and economic consequences, additional studies,
such as interview-based assessments of psychiatrists’
awareness of somatic comorbidities with the verification
of true and false positives by independent assessors, are
needed to investigate this issue.
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